Assessment of the impact of reconstitution therapies—cladribine tablets and alemtuzumab—on the atrophy progression among patients with relapse-remitting multiple sclerosis

IntroductionImmune reconstitution therapies (IRT) are highly effective therapies for multiple sclerosis (MS). Among IRT, we can distinguish partially selective therapies such as cladribine in tablets (CLAD) and non-selective therapies, which include alemtuzumab (ALEM). Today, it is known that these...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Aleksandra Pogoda-Wesołowska, Ignacy Stachura, Arkadiusz Zegadło, Marzena Maciągowska-Terela, Karolina Sobolewska, Aleksander Dębiec, Jacek Staszewski, Adam Stępień
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-02-01
Colecção:	Frontiers in Neuroscience
Assuntos:	reconstitution therapies multiple sclerosis atrophy volumetric changes cladribine tablets alemtuzumab
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fnins.2025.1531163/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!